Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
1,002,623
-
Shares change
-
-558,357
-
Total reported value, excl. options
-
$60,875,954
-
Value change
-
-$33,883,025
-
Put/Call ratio
-
34%
-
Number of buys
-
15
-
Number of sells
-
18
-
Price
-
$60.71
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q1 2019
As of 31 Mar 2019 VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) had 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,002,623 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, CLS Investments, LLC, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, ROYAL BANK OF CANADA, CITADEL ADVISORS LLC, Cerity Partners LLC, LPL Financial LLC, and OPPENHEIMER & CO INC.
This table shows 44 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.